Licensed Medicinal Cannabis · Long Beach, California

Medicinal cannabis,
delivered with care.

ThrivePath Medical is a state-licensed medicinal microbusiness bringing lab-tested cannabis directly to qualified patients across Long Beach and surrounding areas.

Join the Launch List Become a Patient

Our Practice

An apothecary approach to cannabis

ThrivePath Medical was established by operators with deep roots in Long Beach's regulated cannabis industry, with a heritage that reaches back to the city's earliest licensed storefronts and the passage of Measure MM.

As a medicinal-only licensee, our focus is singular: serving patients. Every product on our shelf is sourced from licensed California producers, lab-tested, and tracked seed-to-sale under the state's track-and-trace system.

  • LicenseDCC Microbusiness No. C12-0000654-LIC
  • DEA RegistrationApplication pending (Control ID M00001668J)
  • DesignationMedicinal (M-License)
  • AuthorityCalifornia Department of Cannabis Control
  • Location1501 Santa Fe Avenue, Long Beach

Why Patients Choose Cannabis

Areas of therapeutic interest

Patients turn to medicinal cannabis for a wide range of conditions. Tap any area below to learn what patients commonly report and what the research says.

The most common reason patients seek medicinal cannabis. Many report reduced pain intensity and less reliance on other pain medications. Cannabinoids interact with pain receptors in the brain and spinal cord, modulating how strongly pain signals are processed rather than simply masking them.
ThrivePath Formulation Direction
Cannabinoids
THCCBDCBG
Ratio
1:1 THC:CBD2:1 THC:CBD
Terpenes
MyrceneCaryophylleneLinalool
Delivery
TinctureGummiesTopical

A 1:1 THC:CBD ratio addresses pain while CBD moderates psychoactivity. Myrcene and caryophyllene add anti-inflammatory support. Tinctures allow precise dose titration; topical balm for localized joint or muscle pain.

Cannabinoids in focus
  • THCEngages CB1 receptors along pain-processing pathways; patients commonly report reduced pain intensity.
  • CBDNon-intoxicating; interacts with TRPV1 and inflammatory signaling, and can moderate THC’s psychoactivity.
  • CBGEarly research explores CB2-linked anti-inflammatory activity.
Explore the full cannabinoid guide ↓
Cannabinoids interact with CB2 receptors in the immune system, which play a central role in regulating the body's inflammatory response. This is an area of active research for conditions like arthritis, inflammatory bowel disease, and autoimmune conditions where chronic inflammation is the underlying problem.
ThrivePath Formulation Direction
Cannabinoids
CBDCBGCBC
Ratio
CBD dominantNo THC required
Terpenes
CaryophylleneHumulenePinene
Delivery
TinctureTopicalGummies

CBD, CBG, and CBC all target CB2 receptors without psychoactivity. Caryophyllene is the only terpene that directly activates CB2, making it the primary terpene choice here. Topical cream for localized inflammation; tincture or gummies for systemic conditions.

Cannabinoids in focus
  • CBDThe most-studied cannabinoid for inflammation-related signaling, including cytokine modulation.
  • CBGResearch explores immune-cell CB2 interactions and inflammatory response.
  • THCAThe raw, non-intoxicating acid form of THC, studied for anti-inflammatory potential.
Explore the full cannabinoid guide ↓
Patients with insomnia and disrupted sleep commonly explore cannabis to fall asleep more easily and stay asleep longer. Cannabinoids and terpene profiles rich in myrcene and linalool are associated with a settling, sedative quality that many find supports restful sleep without the grogginess of pharmaceutical sleep aids.
ThrivePath Formulation Direction
Cannabinoids
CBNTHCCBD
Ratio
CBN forwardLow-dose THC
Terpenes
MyrceneLinaloolTerpinolene
Delivery
GummiesTincture

CBN is the cannabinoid most associated with sedation. A low-dose THC addition can deepen sleep onset. Myrcene and linalool are the signature sleep terpenes. Gummies taken 60 minutes before bed, or tincture 30 minutes prior for faster onset.

Cannabinoids in focus
  • CBNA mildly sedating oxidation product of THC; the cannabinoid most associated with nighttime formulations.
  • THCCommonly reported to shorten time to fall asleep; dose strongly influences sleep quality.
  • CBDHigher doses are commonly reported as calming, while low doses can be alerting.
Explore the full cannabinoid guide ↓
Many patients use cannabis to ease anxiety and support a steadier mood. CBD works on serotonin receptors and is an area of growing clinical research. The key is formulation: high-THC products can sometimes heighten anxiety in sensitive patients, while CBD-dominant or balanced ratios tend to have a calming effect without intoxication.
ThrivePath Formulation Direction
Cannabinoids
CBDTHCVCBG
Ratio
CBD dominantMinimal THC
Terpenes
LinaloolLimoneneCaryophyllene
Delivery
TinctureDrink

THCV acts as a CB1 antagonist at lower doses, which can help suppress anxiety-driven responses without sedation. CBD-dominant with linalool and limonene creates a calming-yet-clear profile. Tincture allows quick dose adjustment; beverage format suits daytime use.

Cannabinoids in focus
  • CBDInteracts with serotonin 5-HT1A receptors; the most-studied cannabinoid for calm without intoxication.
  • THCBiphasic: low doses are commonly reported as relaxing, while larger doses can heighten anxiety.
  • CBGEarly patient reports explore mood and stress support.
Explore the full cannabinoid guide ↓
Cannabis is one of the most well-documented tools for stimulating appetite and reducing nausea, especially relevant for patients managing chemotherapy side effects, HIV/AIDS wasting, or eating disorders. THC activates CB1 receptors in the brain regions that regulate hunger and nausea response, often producing results where other antiemetics have failed.
ThrivePath Formulation Direction
Cannabinoids
THCCBDACBD
Ratio
THC forwardWith CBDA
Terpenes
LimoneneOcimeneMyrcene
Delivery
TinctureDrink

CBDA is a potent 5-HT1A agonist, the same receptor targeted by prescription anti-nausea medication, and may be more bioavailable than CBD for this use. THC adds appetite support. Tincture or beverage for faster onset, avoiding the stomach disruption of oral capsules when nausea is active.

Cannabinoids in focus
  • THCActs on CB1 receptors in brainstem regions tied to nausea; prescription THC analogs exist for this use.
  • CBDResearch explores serotonin-linked anti-nausea pathways.
  • CBGEarly research explores appetite support.
Explore the full cannabinoid guide ↓
An FDA-approved cannabis-derived medication (Epidiolex) exists specifically for severe seizure disorders. Beyond epilepsy, research into cannabis for multiple sclerosis, Parkinson's, PTSD, and neurodegenerative conditions is active and growing. Schedule III status is expected to significantly accelerate this research in coming years.
ThrivePath Formulation Direction
Cannabinoids
CBDCBDVCBG
Ratio
CBD dominantCondition specific
Terpenes
PineneLinaloolCaryophyllene
Delivery
TinctureGummies

CBDV is in active clinical trials for Rett syndrome and ASD. Pinene may support cognitive clarity and partially offset THC-related memory effects. Neurological conditions vary significantly; ThrivePath recommends physician-guided formulation with consistent dosing tracked over 4-8 weeks.

Cannabinoids in focus
  • CBDA purified CBD medicine is FDA-approved for certain rare seizure disorders.
  • THCStudied for muscle spasticity, notably in multiple sclerosis, where relief is commonly reported.
  • CBCEarly laboratory research explores neuroprotective signaling.
Explore the full cannabinoid guide ↓
Beyond addressing specific symptoms, long-term patient surveys consistently report improvements in overall wellbeing, daily functioning, and subjective quality of life. Many patients describe feeling more present, more comfortable, and better able to engage in daily activities, even when their underlying condition has not resolved.
ThrivePath Formulation Direction
Cannabinoids
CBDCBGLow THC
Ratio
BalancedPatient guided
Terpenes
LimoneneLinaloolPinene
Delivery
TinctureDrinkGummies

Quality-of-life goals benefit from a balanced, adaptable formulation. A daytime-oriented terpene blend with limonene and pinene supports mood and clarity; switching to linalool and myrcene in the evening supports relaxation and sleep. ThrivePath consultants help patients dial in the right morning and evening split.

Cannabinoids in focus
  • THC:CBDGentle balanced ratios are commonly chosen for overall comfort, mood, and daily function.
  • CBGOften called the mother cannabinoid; early research spans mood, comfort, and focus.
  • THCVAmong the minor cannabinoids under active study for targeted effects.
Explore the full cannabinoid guide ↓
Some patients report reducing their use of opioids, benzodiazepines, sleep aids, and other medications after incorporating medicinal cannabis into their care plan. This should always happen under physician supervision, but it is an area of genuine clinical interest, particularly for pain patients looking to reduce opioid dependence.
ThrivePath Formulation Direction
Cannabinoids
CBDTHCCBG
Ratio
1:1 THC:CBDTitrate slowly
Terpenes
MyrceneCaryophylleneLinalool
Delivery
Tincture

Tincture is strongly preferred here - precise dropper dosing is essential when substituting for a pharmaceutical with a known dose. Tapering should always be done under physician supervision. ThrivePath can work with your care team to document formulation, dosing schedule, and response tracking.

Cannabinoids in focus
  • CBDAffects liver CYP450 enzymes that process many common medications; physician guidance is essential.
  • THC:CBDPatients commonly report reducing reliance on other medications under medical supervision, never on their own.
Explore the full cannabinoid guide ↓
No two patients have the same needs, and no single product works for everyone. Different cannabinoid ratios, delivery methods, and terpene profiles suit different conditions and sensitivities. ThrivePath's approach is to understand your specific situation and guide you toward the formulation most likely to help, then adjust from there.
Our Approach to Personalized Formulation
Step 1
Patient intake
Step 2
Formulation match
Step 3
Trial period
Step 4
Adjust and refine

We start with your condition, sensitivity, lifestyle, and goals. We match a cannabinoid ratio, terpene profile, and delivery format to that picture. After a 2-4 week trial, we review and refine. The goal is a formulation that fits your life, not a generic recommendation.

Individual results vary. These statements have not been evaluated by the FDA. Cannabis is not intended to diagnose, treat, cure, or prevent any disease. Always consult a licensed physician about your condition and whether medicinal cannabis is appropriate for you.

Products in Development

Schedule III formulations built for medicinal intent

ThrivePath is developing a line of precision-formulated medicinal products under Schedule III compliance. Every format is designed around bioavailability, consistent dosing, and patient experience. Available under the ThrivePath brand and through white-label and R&D partnerships.

Active development · Schedule III compliant · Long Beach, CA
ThrivePath GUMMIES PECTIN · 30 COUNT · 10mg Gummies
ThrivePath TONIC WATER SOLUBLE · 250ml nano-emulsified · 10mg CBD Drinks
ThrivePath TOPICAL ThrivePath TOPICAL BOTANICAL · CBD · CBG 60ml · non-intoxicating Topical
ThrivePath TINCTURE SUBLINGUAL · 30ml Tinctures

Partnership Programs

Three ways to work with us

ThrivePath products are available under our own brand and through two structured partnership programs for qualified operators, dispensaries, and research institutions.

01

ThrivePath Brand

Our own label. Sold through our licensed Long Beach dispensary to qualified medicinal patients. Each product developed and quality-controlled in-house, formulated with intention.

02

White Label

Qualified cannabis operators and dispensaries can access ThrivePath formulations under their own brand. We handle formulation, compliance, and consistency. You bring the patient relationship.

03

R&D Licensing

Universities, clinical researchers, and healthcare institutions conducting Schedule III cannabis research can partner with ThrivePath for standardized, compliant cannabinoid formulations tailored to study protocols.

Inquire About Partnership

All programs are subject to licensure verification. Formulations are tailored to each partner, whether patient-facing, research-grade, or retail.

Get in Touch

All products are subject to DCC licensing requirements and applicable Schedule III federal regulations. White label and R&D programs require verified licensure. Nothing here constitutes a commercial offer.

Federal Status

Medical cannabis is now Schedule III, here’s what that means for you

Effective April 2026 · State-Licensed Medical Cannabis

In April 2026, the federal government moved medical cannabis from Schedule I, the same category as heroin, with “no accepted medical use”, to Schedule III, which recognizes accepted medical value and a lower potential for abuse. For licensed medicinal patients and operators like ThrivePath, this is the most significant federal shift in cannabis history. Here is what it actually means in plain terms.

Before, Schedule I

  • Classified alongside heroin, with “no accepted medical use”
  • Federal research on cannabis nearly impossible
  • Businesses taxed on gross revenue, not profit (IRS 280E)
  • No federal recognition of medicinal legitimacy
  • Banking and financial services largely refused

Now, Schedule III

  • Federally recognized as having accepted medical use
  • Research pathways significantly opened
  • 280E tax burden no longer applies to Schedule III operators
  • Medical cannabis placed alongside medications like ketamine
  • Path forward for banking, insurance, and wider access
01

What It Means for You as a Patient

Your medicine is now federally recognized as medicine.

For years, patients using state-licensed medical cannabis existed in a legal grey zone, their state said it was legal and therapeutic, their federal government said it had no medical value. That contradiction is now resolved. Schedule III means the federal government officially acknowledges that cannabis has accepted medicinal use. Your choice to use it is validated at every level of government.

02

Better Products Through More Research

Real clinical research can now happen at scale.

Schedule I status blocked universities, hospitals, and pharmaceutical researchers from studying cannabis properly. The barriers weren’t just legal, funding dried up, approval processes were nearly impossible, and researchers risked their careers. Schedule III removes most of those barriers. Expect a significant acceleration in clinical trials on cannabinoid formulations, dosing, and specific conditions over the next five years.

03

Lower Prices Over Time

The punishing 280E tax no longer applies.

IRS Section 280E prevented cannabis businesses from deducting normal operating expenses, staff, rent, utilities, supplies, because the business was federally classified as trafficking a controlled substance. This meant effective tax rates of 70–90% in some cases, costs that got passed to patients. As a Schedule III medicinal operator, ThrivePath is no longer subject to 280E in the same way. That financial relief makes sustainable, fairly priced medicinal access more achievable.

04

What Hasn’t Changed, and What’s Next

This is not full legalization. But it’s the clearest path toward it.

The April 2026 ruling applies specifically to cannabis dispensed under a qualifying state medical license. Recreational cannabis remains federally Schedule I for now. A DEA administrative hearing beginning June 29, 2026 will consider broader rescheduling. ThrivePath continues to operate in full compliance with all California DCC requirements and applicable federal rules, and will keep patients informed as the landscape evolves.

ThrivePath operates under California DCC License C12-0000654-LIC. The April 2026 federal rescheduling applies to state-licensed medical operators. This page reflects current understanding and will be updated as federal guidance develops. Nothing here constitutes legal advice.

Our Founders

Two decades of shared experience

ThrivePath is led by three partners whose collaboration spans more than twenty years in California's regulated cannabis industry. They have weathered bans, helped write the rules that brought legal cannabis back to Long Beach, and built operations from the ground up, learning the business at every level along the way. The expertise, relationships, and conviction earned across those decades are the foundation of everything ThrivePath builds today.

HA

Haik Aslanian

Co-Founder & CEO

Haik is the architect behind ThrivePath's operational backbone. He directs day-to-day operations and regulatory compliance while overseeing finance and technology, translating complex state and local requirements into systems that simply work. His discipline is the reason the business runs clean, accountable, and audit-ready at every level, giving patients and partners alike the confidence that ThrivePath is built to last.

GL

Greg Lefian

Co-Founder & Public Affairs

Greg is ThrivePath's voice in the community and at the policy table. He works hand in hand with city council, municipal departments, and state regulators, and was a driving force behind the passage of Measure MM. Equally at home with neighbors, local businesses, and patients, he listens first and builds solutions that serve everyone, strengthening both sound cannabis policy and the trust ThrivePath has earned in Long Beach.

AK

Akop Kyutunyan

Co-Founder & General Manager

Akop is the heart of ThrivePath's product program and the steady hand running its daily operation. With more than twenty years immersed in strains, terpenes, and cannabinoids, he partners directly with farms, botanical and natural-terpene producers, and manufacturers to formulate products with real intention, never chasing trends, always chasing what works. His instinct for matching a patient's needs to the right cannabinoid and terpene profile turns a simple recommendation into genuine relief, and has earned the trust of a community that returns to him again and again.

A Shared Legacy

The founders have stood at the center of Long Beach's cannabis movement for over a decade. As founding members of the Long Beach Collective Association (LBCA), they helped lead the fight to bring safe, legal, and regulated cannabis back to the city after the 2012 ban, and were a driving force behind the passage of Measure MM and Measure MA in 2016, the measures that restored medical cannabis to Long Beach and established its regulatory and tax framework.

Through every transition, they have championed patient education, fair policy, and lower cannabis taxes, working hand in hand with city and state regulators. That same advocacy, research, and hard-won experience is now cultivated into ThrivePath.

Exploring the science below? Get launch updates and delivery availability in your inbox while you read.

The Science

The endocannabinoid system

The endocannabinoid system (ECS) is one of the body's master regulators, a signaling network that helps keep physiological processes in balance, from pain and mood to appetite, sleep, and immune response.

Your body produces on demand

AEA
Anandamide
2-AG
Endocannabinoid
Endocannabinoid System
Signals travel backward to calm overactive nerves and regulate immune response
CB1
Nervous system
Brain, spinal cord, nerves. Pain, mood, appetite, memory.
CB2
Immune system
Immune cells, gut. Inflammation, immune regulation.

THC and CBD fit these same receptors, supporting a system your body already built.

ENDOCANNABINOID SYSTEM CB1 CB2 Nervous system Brain, spinal cord, nerves Mood, pain, appetite, memory Immune system Immune cells, gut, tissue Inflammation, immune response AEA & 2-AG The body's own cannabinoids Signal response Receptors restore balance The body's own ligands, anandamide (AEA) and 2-AG, signal through CB1 and CB2 receptors to maintain balance
Receptor · CB1

The nervous system

Concentrated in the brain, spinal cord, and nerves. CB1 signaling influences how the body experiences pain, mood, appetite, and memory by modulating neurotransmitter release.

Receptor · CB2

The immune system

Found mainly in immune cells and peripheral tissue, including the gut. CB2 signaling plays a role in inflammation and immune regulation throughout the body.

AEA Anandamide Natural ligand
2-AG 2-Arachidonoyl­glycerol Natural ligand
CB1 Receptor Nervous system
CB2 Receptor Immune system

The Key Players, tap to explore

Research & Development

The full cannabinoid spectrum

Cannabis produces more than a hundred distinct cannabinoids, each interacting with the ECS differently. ThrivePath works across the full library of legal cannabinoids, exploring custom formulations to help patients find what works for their needs.

Select a cannabinoid to explore its effects
THCTetrahydro­cannabinol
CBDCannabidiol
CBGCannabigerol
CBNCannabinol
CBCCannabichromene
THCVTetrahydro­cannabivarin
CBDVCannabidivarin
CBGACannabigerolic acid
THCATetrahydro­cannabinolic acid
CBDACannabidiolic acid
Formulate

Custom ratios

Precise cannabinoid blends, beyond THC alone, designed around the entourage effect and individual patient goals.

Test

Lab-verified

Every formulation is lab-tested and tracked seed-to-sale, so what's on the label is what's in the product.

Refine

Patient alternatives

An ongoing search for cannabinoid alternatives when conventional approaches fall short, guided by emerging science.

These statements have not been evaluated by the Food and Drug Administration. Cannabis products are not intended to diagnose, treat, cure, or prevent any disease. Information here is educational and not medical advice. Consult a licensed physician about your individual needs.

Understanding Terpenes

The aromatic compounds that shape the experience

Terpenes are the natural aromatic molecules found in every plant. They are why lavender smells calming, why citrus feels energizing, and why a pine forest has that particular clarity. Cannabis is exceptionally rich in terpenes, and each variety carries its own unique blend. Beyond scent, terpenes interact with cannabinoids to shape the overall effect, which is why two products with identical THC levels can feel completely different. Tap any terpene to learn more.

Also found in: Mango, hops, lemongrass, thyme

Myrcene is the most common terpene in cannabis. It is responsible for that deep, earthy, slightly fruity base note you smell in many varieties. You have already encountered it, that warm, musky sweetness in a ripe mango is mostly myrcene. It is widely associated with a relaxing, body-settling quality and is thought to help other cannabinoids absorb more easily.

Relaxing Sedating Body ease Sleep support

Also found in: Lemon and orange peel, grapefruit, cleaning products

Limonene is the bright, clean citrus smell you get when you peel an orange or walk past a lemon tree. It is one of the most recognizable aromas in the world and in cannabis it brings that same lift. Varieties high in limonene tend to feel more uplifting and energetic. It is also being studied for its effects on mood and stress.

Mood uplift Energy Stress relief Focus

Also found in: Pine trees, rosemary, basil, dill

Pinene is the smell of a pine forest, clean, sharp, and immediately clarifying. It is one of the most abundant terpenes in nature. In cannabis it is associated with mental clarity and alertness. Pinene may also counteract some short-term memory effects of THC, which is why it shows up in some balanced formulations.

Alertness Mental clarity Anti-inflammatory Memory support

Also found in: Lavender, rose, coriander, bergamot

Linalool is literally the compound that makes lavender smell like lavender. That calm, floral, slightly sweet scent that people have used for centuries to wind down and sleep, that is linalool. In cannabis it brings the same quality. If you have ever found lavender aromatherapy soothing, you have already experienced linalool working.

Anxiety relief Sleep Calming Mood ease

Also found in: Black pepper, cloves, cinnamon, basil

Activates CB2 receptors, unique among terpenes

Caryophyllene is the spicy warmth in black pepper, that slight tingle you get when you smell freshly ground pepper. What makes it special is that it is the only terpene known to directly interact with the body's cannabinoid receptors, specifically CB2, the immune and inflammation system. That means it acts like a cannabinoid itself, making it particularly useful for inflammation and pain without any intoxicating effect.

Anti-inflammatory Pain relief Anxiety ease No high

Also found in: Apples, nutmeg, tea tree, lilac

Terpinolene is harder to pin down than the others. It is a blend of fruity, floral, herbal, and slightly piney all at once, which is why it reads as fresh and complex. Think of biting into a crisp apple in a room with flowers. It is less common in cannabis than myrcene or limonene, but when it appears it tends to bring an uplifting, slightly stimulating quality.

Uplifting Antioxidant Lightly stimulating

Also found in: Hops (beer), ginger, ginseng, sage

Humulene is the earthy, woody, slightly bitter note you detect in a craft beer, it is the signature terpene of hops. In cannabis it adds a grounding, herbal depth. It is associated with anti-inflammatory properties and may suppress appetite rather than stimulate it, making it notable in a plant most associated with the munchies.

Anti-inflammatory Appetite suppression Grounding

Also found in: Mint, basil, parsley, orchids, tarragon

Ocimene is a light, fresh, sweet-herbal terpene, the kind of clean green scent you get from a bunch of fresh basil or a sprig of mint. In cannabis it tends to appear as a top note, the first thing your nose catches before the deeper earthy or floral tones settle in. Often present in daytime-oriented varieties.

Uplifting Decongestant Fresh energy

No two patients are alike and neither are their terpene needs. ThrivePath works directly with farms and botanical terpene producers to formulate products with specific profiles in mind. Tell us what you are trying to address, sleep, pain, anxiety, energy, and our team will guide you to a terpene and cannabinoid combination matched to your goal.

Personalized Expert guided Medicinal focus

Terpene effects reflect commonly reported associations and ongoing research, not guaranteed medical outcomes. Individual responses vary.

Patient Information

How to become a ThrivePath patient

ThrivePath is a licensed medicinal cannabis dispensary serving qualified patients in Long Beach and surrounding areas. Here is everything you need to know before your first order.

01

Get a Physician Recommendation

You need a valid California physician's recommendation for medicinal cannabis. Your primary care doctor can provide one, or you can use a telemedicine service like NuggMD or Leafwell. The recommendation must be current.

02

Register as a Patient

Contact us with your physician's recommendation and a valid government-issued photo ID. Our team will verify your eligibility and set up your patient account before your first order.

03

Place Your First Order

Once registered, order by phone or online. Our team will help you find the right formulation for your needs. Delivery to Long Beach and surrounding areas, with ID verification at handoff.

Get in Touch

Contact ThrivePath

Email

info@thrivepathmedical.com

General inquiries, patient registration, partnership questions

Address

1501 Santa Fe Avenue
Long Beach, CA 90813

View on Google Maps

Hours

Mon – Sat: 9:00 AM – 8:00 PM
Sunday: 10:00 AM – 6:00 PM

Hours subject to change. Check back for updates.

License

DCC License C12-0000654-LIC

Verify at search.cannabis.ca.gov

Common Questions

What patients ask us

Yes. ThrivePath is a medicinal-only dispensary. You need a valid California physician's recommendation for medicinal cannabis, plus a government-issued photo ID. If you don't have a recommendation yet, telemedicine services like NuggMD or Leafwell can connect you with a licensed California physician for a same-day evaluation, usually for under $50.
Medical cannabis is purchased by patients with a physician's recommendation and is subject to a lower tax rate in California. Medical patients can also purchase higher quantities and access formulations not available in adult-use dispensaries. ThrivePath is licensed exclusively for medicinal sales, which means every product on our shelf is selected for therapeutic intent, not novelty.
Not currently. Health insurance in the US does not cover cannabis purchases, even with a physician's recommendation. This is largely a consequence of the prior federal Schedule I classification. With Schedule III status now in effect, it is expected that the conversation around insurance reimbursement will develop, but no coverage exists at this time. We accept cash and debit. Credit card acceptance varies and will be confirmed when patient services launch.
All delivery is conducted by a licensed ThrivePath driver in an unmarked vehicle. Your order is packaged in plain, sealed bags with no cannabis branding visible on the outside. The driver will verify your ID and physician's recommendation at the door before handing over your order. Delivery is available to qualifying addresses in Long Beach and surrounding areas, with specific zones and minimums to be published when patient services commence.
Start with our team. Tell us your condition, your goals, and any concerns, including whether you want to avoid feeling high. We will walk you through the formulation options that fit your situation, starting with the lowest effective dose and the delivery format most appropriate for your needs. Many first-time patients start with a CBD-dominant tincture or a low-dose 1:1 gummy. There is no pressure and no rush. We would rather you feel confident than overwhelmed.
Yes. ThrivePath Medical LLC holds California DCC License C12-0000654-LIC and operates in full compliance with the California Department of Cannabis Control, the City of Long Beach, and applicable federal requirements under the April 2026 Schedule III designation. All products are lab-tested and tracked seed-to-sale through the state's METRC track-and-trace system. You can verify our license at search.cannabis.ca.gov.
We are actively preparing for launch and expect to begin patient services in Q4 2026. Sign up for our mailing list and you will be among the first to know when ordering opens. If you have an urgent need or want to be on the early patient list, email us at info@thrivepathmedical.com.

ThrivePath does not provide medical advice. All information on this site is educational. Consult a licensed physician about your condition and whether medicinal cannabis is appropriate for you.

Delivery & Location

Serving Long Beach

Delivery Check

Do we deliver to you?

Enter your ZIP code and email. We’ll tell you if you’re in our planned delivery area and notify you the day delivery opens.

Delivery Area

Long Beach and surrounding areas

Delivery zones and order minimums will be published when patient services commence.

Order & Contact

Phone and online ordering will be available when patient services commence.

Walk-Ins

1501 Santa Fe Avenue
Long Beach, CA 90813

Open in Google Maps · Hours posted at opening

Verify Our License

Look up C12-0000654-LIC at search.cannabis.ca.gov